Journal Articles Frontiers in Aging Neuroscience Year : 2016

In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid Immunotherapy

Abstract

Extracellular deposition of β amyloid plaques is an early event associated to Alzheimer's disease. Here, we have used in vivo gadolinium-stained high resolution (29 * 29 * 117 µm 3) magnetic resonance imaging (MRI) to follow-up in a longitudinal way individual amyloid plaques in APP/PS1 mice and evaluate the efficacy of a new immunotherapy (SAR255952) directed against protofibrillar and fibrillary forms of Aβ. APP/PS1 mice were treated for 5 months between the age of 3.5 and 8.5 months. SAR255952 reduced amyloid load in 8.5-months-old animals, but not in 5.5-months animals compared to mice treated with a control antibody (DM4). Histological evaluation confirmed the reduction of amyloid load and revealed a lower density of amyloid plaques in 8.5-months SAR255952-treated animals. The longitudinal follow-up of individual amyloid plaques by MRI revealed that plaques that were visible at 5.5 months were still visible at 8.5 months in both SAR255952 and DM4-treated mice. This suggests that the amyloid load reduction induced by SAR255952 is related to a slowing down in the formation of new plaques rather than to the clearance of already formed plaques.

Fichier principal
Vignette du fichier
santin2016fnagi.pdf (1.62 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
Licence
Loading...

Dates and versions

hal-02155734 , version 1 (13-06-2019)

Licence

Identifiers

Cite

Mathieu D. Santin, Michel Vandenberghe, Anne-Sophie Herard, Laurent Pradier, Caroline Cohen, et al.. In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid Immunotherapy. Frontiers in Aging Neuroscience, 2016, 8, ⟨10.3389/fnagi.2016.00055⟩. ⟨hal-02155734⟩
329 View
175 Download

Altmetric

Share

  • More